These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25042725)

  • 1. Lysability of fibrin clots is a potential new determinant of stroke risk in atrial fibrillation.
    Skov J; Sidelmann JJ; Bladbjerg EM; Jespersen J; Gram J
    Thromb Res; 2014 Sep; 134(3):717-22. PubMed ID: 25042725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Denser plasma clot formation and impaired fibrinolysis in paroxysmal and persistent atrial fibrillation while on sinus rhythm: association with thrombin generation, endothelial injury and platelet activation.
    Drabik L; Wołkow P; Undas A
    Thromb Res; 2015 Aug; 136(2):408-14. PubMed ID: 26048399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin Clot Permeability as a Predictor of Stroke and Bleeding in Anticoagulated Patients With Atrial Fibrillation.
    Drabik L; Wołkow P; Undas A
    Stroke; 2017 Oct; 48(10):2716-2722. PubMed ID: 28904234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender Differences in Fibrin Polymerization and Lysability of Fibrin in Patients with Atrial Fibrillation.
    Gram J; Skov J; Bladbjerg EM; Sidelmann J; Jespersen J
    J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):292-7. PubMed ID: 26521168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assays of fibrin network properties altered by VKAs in atrial fibrillation - importance of using an appropriate coagulation trigger.
    Ząbczyk M; Blombäck M; Majewski J; Karkowski G; Wallen HN; Undas A; He S
    Thromb Haemost; 2015 Apr; 113(4):851-61. PubMed ID: 25518887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboembolic events are associated with prolonged clot lysis time in patients with permanent atrial fibrillation.
    Ząbczyk M; Majewski J; Lelakowski J
    Pol Arch Med Wewn; 2011 Nov; 121(11):400-7. PubMed ID: 22064373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation.
    Aulin J; Siegbahn A; Hijazi Z; Ezekowitz MD; Andersson U; Connolly SJ; Huber K; Reilly PA; Wallentin L; Oldgren J
    Am Heart J; 2015 Dec; 170(6):1151-60. PubMed ID: 26678637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation.
    Lip GY; Rushton-Smith SK; Goldhaber SZ; Fitzmaurice DA; Mantovani LG; Goto S; Haas S; Bassand JP; Camm AJ; Ambrosio G; Janský P; Al Mahmeed W; Oh S; van Eickels M; Raatikainen P; Steffel J; Oto A; Kayani G; Accetta G; Kakkar AK;
    Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S12-20. PubMed ID: 25714828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
    Konieczynska M; Fil K; Bazanek M; Undas A
    Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction therapy alters plasma fibrin clot properties in multiple myeloma patients: association with thromboembolic complications.
    Undas A; Zubkiewicz-Usnarska L; Helbig G; Woszczyk D; Kozińska J; Dmoszyńska A; Dębski J; Podolak-Dawidziak M; Kuliczkowski K
    Blood Coagul Fibrinolysis; 2015 Sep; 26(6):621-7. PubMed ID: 26083985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clot Lysis Time Predicts Stroke During Anticoagulant Therapy in Patients with Atrial Fibrillation.
    Drabik L; Konieczyńska M; Undas A
    Can J Cardiol; 2020 Jan; 36(1):119-126. PubMed ID: 31740169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of renal function on whole blood and fibrin clot formation in atrial fibrillation patients on warfarin.
    Lau YC; Xiong Q; Lip GY; Blann AD
    Ann Med; 2016; 48(4):275-81. PubMed ID: 27043881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study.
    Xiang W; Zhang J; Liu M; Liu F; Feng X; Wang Y
    Clin Interv Aging; 2015; 10():515-9. PubMed ID: 25767378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prothrombotic State in Patients With a Left Atrial Appendage Thrombus of Unknown Origin and Cerebrovascular Events.
    Meus R; Son M; Sobczyk D; Undas A
    Stroke; 2016 Jul; 47(7):1872-8. PubMed ID: 27301942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis.
    Lip GY; Patel JV; Hughes E; Hart RG
    Stroke; 2007 Apr; 38(4):1229-37. PubMed ID: 17332453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated NT-proBNP is associated with unfavorably altered plasma fibrin clot properties in atrial fibrillation.
    Matusik PT; Matusik PS; Kornacewicz-Jach Z; Małecka B; Ząbek A; Undas A
    Int J Cardiol; 2017 Sep; 243():244-250. PubMed ID: 28571619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
    Roldán V; Marín F; Manzano-Fernandez S; Fernández H; Gallego P; Valdés M; Vicente V; Lip GY
    Thromb Haemost; 2013 May; 109(5):956-60. PubMed ID: 23572113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey.
    Marcucci M; Lip GY; Nieuwlaat R; Pisters R; Crijns HJ; Iorio A
    Am J Med; 2014 Oct; 127(10):979-986.e2. PubMed ID: 24838192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prothrombotic State in Atrial Fibrillation Patients With One Additional Risk Factor of the CHA
    Głowicki B; Matusik PT; Plens K; Undas A
    Can J Cardiol; 2019 May; 35(5):634-643. PubMed ID: 30955928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.